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ABSTRACT 18 
Deletion or truncation of NS1, the principal interferon (IFN) antagonist of 19 
influenza viruses, leads to increased IFN induction during influenza virus 20 
infection. We have studied activation of the IFN induction cascade by both 21 
wildtype and NS1-defective viruses at the single-cell level using a cell line 22 
expressing GFP under the control of the IFN- promoter and by examining MxA 23 
expression. The IFN- promoter was not activated in all infected cells, even 24 
during NS1-defective virus infections. Loss of NS1 expression is therefore by 25 
itself insufficient to induce IFN in an infected cell, and factors besides NS1 26 
expression status must dictate whether the IFN response is activated. The IFN 27 
response was efficiently stimulated in these cells following infection with other 28 
viruses; the differential IFN response we observe with influenza viruses is 29 
therefore not cell-specific, but is likely due to differences in the nature of the 30 
infecting virus particles and their subsequent replication. 31 
 32 
TEXT 33 
The interferon (IFN) arm of the innate immune response restricts virus replication 34 
and spread during in vivo virus infections prior to activation of the adaptive 35 
immune system. Recognition of certain viral molecular structures (pathogen 36 
associated molecular patterns; PAMPs) as non-self by pathogen recognition 37 
receptors (PRRs) enable an infected cell to detect the presence of a virus and 38 
activate the IFN induction cascade, leading to stimulation of the IFN promoter, 39 
IFN expression and secretion. IFN then elicits an ‘antiviral state’ in infected cells 40 
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or surrounding uninfected cells through the upregulation of hundreds of different 41 
interferon-stimulated genes (ISGs) that possess either direct or indirect antiviral 42 
activity in order to efficiently limit further replication and spread of the virus 43 
(reviewed in (Randall and Goodbourn, 2008)). For influenza A viruses, a 44 
predominant PAMP is believed to be the region of partially double-stranded, 5’-45 
triphosphorylated RNA that forms between the partially complementary termini of 46 
the influenza A virus genome segments (Baum et al., 2010, Rehwinkel et al., 47 
2010); stretches of dsRNA directly adjacent to a 5’-triphosphate can function as 48 
ligands for the PRR RIG-I, which has been shown to be critical for IFN induction 49 
during influenza A virus infections (Kato et al., 2006). However, these genome 50 
segments do not generally exist as free RNA but are encapsidated by viral 51 
nucleoprotein (NP) and polymerase to form ribonucleoproteins (RNPs), which are 52 
likely to impact the ability of RIG-I to recognise viral genomes. The precise origin 53 
of influenza virus PAMPs during infection is therefore still unclear, and 54 
contradictory reports exist on the importance of incoming RNPs and the 55 
requirements for viral RNA synthesis for the induction of IFN (Killip et al., 2014, 56 
Weber et al., 2015). Additionally, although RIG-I has long been considered the 57 
PRR for influenza virus, MDA5 was recently implicated as performing a more 58 
significant role in this process than previously thought (Benitez et al., 2015), 59 
indicating several distinct PAMPs that stimulate different PRRs could be 60 
generated during the course of an influenza virus infection. 61 
 62 
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Like other viruses, influenza virus encodes factors that antagonise the IFN 63 
response in order to be able to replicate efficiently. Although other viral proteins 64 
have been reported to modulate IFN expression (Dudek et al., 2011, Varga et al., 65 
2011, Graef et al., 2010, Iwai et al., 2010), the principal of these is the NS1 66 
protein, which limits IFN expression at several different stages of the IFN 67 
induction pathway and can additionally inhibit the expression and/or function of 68 
ISG products downstream. As a result, viruses with NS1 deletions or truncations 69 
induce large amounts of IFN and are attenuated in IFN-competent systems 70 
(Garcia-Sastre et al., 1998, Egorov et al., 1998, Kochs et al., 2007b). The RNA-71 
binding domain of NS1 has been implicated in preventing activation of the IFN- 72 
promoter during infection by sequestering double-stranded RNA away from 73 
PRRs, and recombinant viruses expressing RNA binding mutants of NS1 induce 74 
higher levels of IFN than wildtype (wt) virus (Qian et al., 1995, Newby et al., 75 
2007, Donelan et al., 2003, Steidle et al., 2010b). NS1 also inhibits RIG-I and 76 
downstream IFN induction by targeting the TRIM25 ubiquitin ligase that is 77 
required for RIG-I activation (Gack et al., 2009, Guo et al., 2007, Mibayashi et al., 78 
2007, Opitz et al., 2007). Post-transcriptional inhibition of IFN expression by NS1 79 
additionally occurs through the binding and inhibition of the 30kDa subunit of the 80 
cellular cleavage and polyadenylation specificity factor (CPSF30) which prevents 81 
the processing of all cellular pre-mRNA 3’-ends, thereby globally limiting the 82 
expression of host genes including IFN- and ISGs (Twu et al., 2006, Noah et al., 83 
2003, Das et al., 2008, Hayman et al., 2006). The relative contribution of each of 84 
these functions towards overall limiting of IFN expression differs between virus 85 
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strains, since some strains do not target CPSF30 while others are unable to 86 
prevent IFN induction upstream of the IFN promoter (Kuo et al., 2010, Hayman et 87 
al., 2006). 88 
 89 
Most previous studies examining IFN induction by influenza viruses have used 90 
methods that give an indication of the average response across a cell population; 91 
consequently there exists little information on the activation of innate immune 92 
responses to influenza virus infection at the single cell level. In this study, we 93 
have extended our previous work into the examination of IFN induction at the 94 
single-cell level by negative-sense RNA viruses (Chen et al., 2010, Killip et al., 95 
2015, Killip et al., 2011) to study IFN induction by influenza viruses in greater 96 
depth. Activation of the IFN induction cascade in individual infected cells was 97 
examined using the A549/pr(IFN-).GFP cell-line; these human lung epithelial 98 
cells express GFP under the control of the IFN- promoter and consequently 99 
respond very effectively to IFN inducers, including synthetic dsRNA and stocks of 100 
paramyxoviruses that are rich in defective viruses (Fig. 1 A-B)(Chen et al., 2010, 101 
Killip et al., 2011, Killip et al., 2013, Killip et al., 2012). As we have reported 102 
previously (Chen et al., 2010, Killip et al., 2015), GFP expression in cells infected 103 
with A/Udorn/72 (Udorn; H3N2) and A/Puerto Rico/8/34 (PR8; H1N1) influenza A 104 
viruses was observed only in a very low percentage of infected (i.e. NP-positive) 105 
cells (0.25% and 1.16%, respectively) (Fig. 1A). While this result clearly indicates 106 
that the majority of infected cells are negative for IFN-β.GFP expression, this 107 
does not necessarily mean that the IFN induction cascade has not been activated 108 
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upstream of GFP protein expression in these GFP-negative cells. In cells infected 109 
with certain strains of influenza virus, the IFN-β promoter can be activated and 110 
IFN-β pre-mRNA generated yet mature IFN-β mRNA and IFN-β protein is not 111 
expressed due to NS1-mediated inhibition of CPSF30 activity (Kuo et al., 2010). 112 
As such, viruses that target CPSF30 (including Udorn wt) prevent expression 113 
from both constitutively active and inducible promoters, which has implications for 114 
the expression of IFN and interferon-stimulated genes (Hayman et al., 2006). 115 
Consistent with this, considerable IRF3 activation (an indicator of IFN induction 116 
upstream of the IFN-β promoter) can be detected by western blot in Udorn wt-117 
infected A549/pr(IFN-).GFP cells yet GFP expression cannot be detected (Fig. 118 
1B). However, this was not the case for PR8 wt-infected cells in which IRF3 119 
activation correlated with GFP expression (Fig. 1B), consistent with the inability 120 
of this virus to inhibit CPSF30 (Kochs et al., 2007a, Kuo and Krug, 2009, Hayman 121 
et al., 2006, Steidle et al., 2010a).  122 
 123 
Given the well-described role of NS1 in limiting IFN induction, we sought to 124 
examine the effect of deleting NS1 on expression of our IFN-β reporter by 125 
infecting A549/pr(IFN-).GFP cells with influenza viruses that lack a functional 126 
NS1 protein. Ud-99/R38A, a recombinant Udorn virus, has an R38A mutation in 127 
the RNA-binding domain that abrogates the dsRNA-binding activity of the NS1 N-128 
terminus (Wang et al., 1999, Min and Krug, 2006) and lacks most of the C-129 
terminal effector domain of NS1 (Jackson et al., 2010). Consequently, Ud-130 
99/R38A also lacks binding sites for TRIM25 and CPSF30 (Gack et al., 2009, 131 
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Twu et al., 2006, Kuo and Krug, 2009) and IRF3 activation in cells infected with 132 
Ud-99/R38A therefore correlates well with GFP expression, unlike the parental 133 
Udorn wt virus (Fig. 1B). PR8-NS1 has a complete NS1 gene deletion in the 134 
PR8 background (Garcia-Sastre et al., 1998). Consistent with a loss of IFN-135 
antagonist activity, both Ud-99/R38A and PR8-NS1 induce considerably more 136 
IFN secretion than their respective wildtype viruses from infected cell monolayers 137 
(Fig. 1C). When activation of the IFN induction cascade by these viruses was 138 
examined by flow cytometry, infection with Ud-99/R38A- and PR8-NS1 139 
resulted in a higher number of GFP-positive infected cells (Fig. 1D-E) than seen 140 
for Ud wt or PR8 wt (Fig. 1A), due to alleviation of the NS1-mediated inhibition of 141 
IFN expression that exists during wt virus infections. However, strikingly, a 142 
considerable number of infected cells that were strongly positive for viral protein 143 
remained negative for GFP, indicating that the IFN induction cascade had not 144 
been activated, despite viral replication occurring in these cells. In contrast, our 145 
positive controls in these experiments, paramyxovirus preparations rich in 146 
defective viruses (including the Cantell preparation of Sendai virus, which like 147 
influenza virus is known to generate RIG-I ligands (Baum et al., 2010, Strahle et 148 
al., 2007)), induced GFP in the majority of infected cells (Fig. 1A,D,F). In support 149 
of our flow cytometry data, cells that are positive for viral protein but negative for 150 
GFP expression were also clearly seen by microscopy (Fig. 1F). This 151 
heterocellular pattern of IFN-β promoter activation that was not due to examining 152 
GFP expression too early or too late in infection, since it was observed over a 153 
timecourse of Ud-Δ99/R38A infection: by 8h p.i., the majority of cells were 154 
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positive for viral NP and GFP-positive cells could be detected in small numbers 155 
(Fig. 2). The number of GFP-positive cells peaked at 16h p.i. and remained 156 
stable until 24h, when cell death leads to a slight drop in GFP expression due to 157 
the apoptogenic nature of the Δ99 NS1 deletion (Jackson et al., 2010).   158 
 159 
We have clearly demonstrated that an IFN- reporter gene is not expressed in a 160 
subpopulation of cells infected with NS1-defective influenza viruses, despite the 161 
multitude of ways in which NS1 functions to limit IFN induction during wt virus 162 
infections. We next examined expression of an endogenous marker of activation 163 
of the IFN response, the ISG product MxA, in A549/pr(IFN-).GFP monolayers 164 
infected with PR8-ΔNS1. Basal MxA expression was low in uninfected cells but 165 
was upregulated following treatment with exogenous IFN or infection with SeV 166 
Cantell (Fig. 3). At low dilutions of PR8-ΔNS1, in regions of the cell monolayer in 167 
which several GFP-positive cells were present, the surrounding uninfected cells 168 
were MxA-positive; this was consistent with IFN having been secreted from GFP-169 
positive cells and eliciting an antiviral state in neighbouring uninfected cells. At 170 
higher dilutions of PR8-ΔNS1, fields of view containing one or two infected cells 171 
could be detected since PR8 does not undergo multi-cycle replication in tissue 172 
culture unless trypsin is added to the culture media. In fields of view containing 173 
NP-positive, GFP-positive cells at a high dilution of virus, surrounding uninfected 174 
cells were positive for MxA indicating the establishment of an antiviral state in 175 
these cells (Fig. 3: NP-positive/GFP-positive panel). In contrast, uninfected cells 176 
surrounding cells that were strongly NP-positive but GFP-negative were negative 177 
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for MxA (Fig. 3: NP-positive/GFP-negative panel), strongly suggesting that IFN 178 
had not been secreted from these infected cells.  179 
 180 
Using an IFN-β reporter gene system and endogenous MxA expression studies, 181 
we have demonstrated that both wt viruses and viruses lacking a functional NS1 182 
protein, which are incapable of efficiently inhibiting IFN production and are robust 183 
activators of the IFN response in cell populations, stimulated IFN induction 184 
pathways in only a subset of infected cells. Thus, only a subset of infected cells is 185 
likely to be responsible for secreting the IFN that is detectable during both wt and 186 
NS1-defective virus infections. A previous study used an IFN-β-luciferase mouse 187 
model to study the cell types responsible for IFN secretion in the infected mouse 188 
lung and found that luciferase expression was restricted to relatively few 189 
epithelial cells and macrophages that had been infected with both the wt and an 190 
NS1-deletion mutant of the mouse-adapted H7N7 SC35M strain (Kallfass et al., 191 
2013). Furthermore, such differential expression has similarly been noted for 192 
ISGs, with only about 20% of cells infected with an NS1-deletion mutant of the 193 
A/Panama/2007/1999 strain going on to express ISG15 (von Recum-Knepper et 194 
al., 2015).  In the in vivo study by Kalfass and colleagues, differences in the 195 
susceptibility of cell types to influenza virus infection or cell-to-cell variability in 196 
the ability to mount an IFN response may have contributed to the differential IFN-197 
 promoter activation between cells. In our study, these potential sources of 198 
variability have been eliminated; the subcloned A549/pr(IFN-).GFP reporter cell 199 
line can respond relatively uniformly to IFN inducers (Fig.1A,D,E,F)(Chen et al., 200 
Downloaded from www.microbiologyresearch.org by
IP:  194.82.50.2
On: Mon, 30 Jan 2017 14:09:42
 10 
2010, Killip et al., 2011, Killip et al., 2013). Our data thus provide evidence that 201 
these cells are differentially mounting an IFN response due to differences in the 202 
nature of the infecting virus particles and their subsequent replication, rather than 203 
cell-specific factors. Indeed, we have shown previously that different preparations 204 
of the same PR8 virus activate the IFN response to very different degrees (Killip 205 
et al., 2015).  206 
 207 
We have demonstrated that influenza viruses that are defective in NS1, the 208 
principal IFN antagonist, have the ability to enter cells and replicate without 209 
leading to IFN induction. While we cannot rule out that other viral proteins, such 210 
as PB2 or PB1-F2, which have been previously reported to inhibit IFN induction 211 
(Graef et al., 2010, Dudek et al., 2011, Iwai et al., 2010, Varga et al., 2011), are 212 
actively inhibiting IFN induction downstream of PAMP recognition in cells infected 213 
with an NS1-deficient virus, we favour the interpretation that the replication cycle 214 
of influenza viruses is such that it is likely the virus can replicate without 215 
generating or exposing PAMPs (e.g. by replicating in the nucleus, in a different 216 
subcellular compartment to the cytoplasmic PRRs, and by efficiently 217 
encapsidating the viral vRNA genome and its full-length complement cRNA into 218 
RNPs), thereby preventing activation of the IFN response during normal virus 219 
replication  (reviewed in (Killip et al., 2015)). Furthermore, our data do not 220 
support a significant role for incoming genomes in IFN induction, as has been 221 
reported previously (Weber et al., 2013, Weber et al., 2015), since the majority of 222 
cells infected with NS1-defective viruses do not express markers of IFN response 223 
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activation despite all cells having been exposed to incoming nucleocapsids. 224 
Interestingly, RIG-I has been reported to recognise RNPs from avian influenza 225 
viruses more readily than those from human viruses (Weber et al., 2015); thus, 226 
species-specific differences could exist in the number of cells expressing IFN 227 
following infection with NS1-deficient viruses of human or avian origin.  228 
 229 
Our results suggest that factors in addition to NS1 expression status determine 230 
the IFN activation status of a cell infected with influenza virus, and that the 231 
triggering of IFN induction pathways is likely to be associated with some form of 232 
aberrant replication, e.g. inefficient genome encapsidation, the generation of 233 
aberrant RNA products or the replication of defective genomes. There is 234 
accumulating evidence pointing to the involvement of the latter in this process 235 
(Killip et al., 2015, Baum et al., 2010, Frensing et al., 2014, Ngunjiri et al., 2013, 236 
Scott et al., 2011a, Scott et al., 2011b, Perez-Cidoncha et al., 2014, Tapia et al., 237 
2013), and a link between defective genomes and IFN induction is well-238 
documented for other negative-sense RNA virus families. Thus, rather than being 239 
required to limit IFN production in cells in which virus is replicating normally, the 240 
primary function of NS1 may be to limit IFN induction in the event of these 241 
aberrant replication events occurring.  242 
 243 
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FIGURE LEGENDS 435 
 436 
 437 
Fig. 1: Failure to activate the IFN- promoter by NS1-defective influenza A 438 
viruses.  439 
(A) A549/pr(IFN-).GFP cells were uninfected or infected with Ud wt, PR8 wt or 440 
Sendai virus (SeV) Cantell at 5 PFU/cell. At 16h p.i., cells were trypsinised, fixed, 441 
permeabilised and immunostained with antibody against influenza virus NP and 442 
subsequently analysed for NP and GFP expression by flow cytometry. Cells were 443 
divided into quadrants according to intensity of NP and GFP expression and the 444 
percentage of cells in each quadrant is indicated on each graph. (B) Cell lysates 445 
were generated from A549/pr(IFN-).GFP monolayers infected with Ud wt, Ud-446 
Δ99R38A, PR8 wt or PR8-ΔNS1 at 5PFU/cell or uninfected cells for 16h p.i., then 447 
subjected to SDS-PAGE and immunoblotting with antibodies specific to phospho-448 
IRF3, GFP, viral proteins and actin. (C) Cells were treated as in B. IFN present in 449 
culture media was estimated by a CPE-reduction bio-assay (Killip et al., 2013). 450 
Error bars represent the results of three independent experiments. (D,E) 451 
A549/pr(IFN-).GFP cells were uninfected or infected with Ud-99/R38A or PR8-452 
ΔNS1 at the multiplicities indicated on the plots. At 16h p.i., cells were 453 
trypsinised, fixed, permeabilised and immunostained for influenza virus HA or NP 454 
expression as indicated. PIV5-VΔC vM2 (Killip et al., 2012) or SeV Cantell 455 
infections were also carried out as positive controls for GFP expression. Cells 456 
were analysed by flow cytometry as in A. (F) Cells were infected as in D and E. 457 
At 16h p.i., cells were fixed, permeabilised and immunostained for influenza virus 458 
NP. GFP, NP (red) and nuclei (stained with DAPI; grey) were visualised by 459 
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confocal microscopy. Arrows mark those cells that are strongly positive for virus 460 
antigen but in which GFP cannot be detected.  461 
 462 
Fig. 2: Timecourse of GFP expression in A549/pr(IFN-).GFP cells during 463 
infection with an NS1-defective IAV.   464 
 465 
A549/pr(IFN-).GFP cells were infected with Ud-Δ99/R38A at 5 PFU/cell. At the 466 
indicated times post-infection, cells were trypsinised, fixed, permeabilised and 467 
immunostained for NP expression. GFP and NP expression were subsequently 468 
analysed by flow cytometry. The percentage of cells positive for NP and the 469 
percentage of cells positive for both NP and GFP at each timepoint are plotted. 470 
Flow cytometry plots at selected timepoints are shown below the graph. 471 
 472 
Figure 3: Heterogeneity in the induction of an antiviral state in uninfected 473 
cells surrounding NS1-defective IAV-infected cells.   474 
 475 
A549/pr(IFN-).GFP cells were infected with low or high dilutions of PR8-ΔNS1 476 
as indicated, uninfected or infected with SeV Cantell as a positive control for GFP 477 
expression. As a positive control for MxA expression, cells were treated with IFN-478 
α (1000 IU/ml). Cells were fixed at 16h p.i., permeabilised and immunostained for 479 
influenza virus NP and MxA. Nuclear material was stained with DAPI. GFP, MxA, 480 
NP and DAPI staining were examined by confocal microscopy. Arrows mark the 481 
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positions of NP-positive cells that are either GFP-positive and surrounded by 482 
MxA-positive cells, or are GFP-negative and surrounded by MxA-negative cells.  483 
 484 
 485 
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